CDX2 and neoplasm: No relevant difference was noted among the two etiologically different tumour groups concerning cumulative intestinal marker expression (p=0.556); however, the percentage of cases with CDX2 expression turned out to be significantly lower (p=0.007) in CrD-SBCs.